• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过尾静脉液压注射进行质粒递送的机制。I. 各种分子的肝细胞摄取。

Mechanism of plasmid delivery by hydrodynamic tail vein injection. I. Hepatocyte uptake of various molecules.

作者信息

Sebestyén Magdolna G, Budker Vladimir G, Budker Tatiana, Subbotin Vladimir M, Zhang Guofeng, Monahan Sean D, Lewis David L, Wong So C, Hagstrom James E, Wolff Jon A

机构信息

Mirus Bio Corporation, 505 S. Rosa Rd., Madison, WI 53719, USA.

出版信息

J Gene Med. 2006 Jul;8(7):852-73. doi: 10.1002/jgm.921.

DOI:10.1002/jgm.921
PMID:16724360
Abstract

BACKGROUND

The hydrodynamic tail vein (HTV) injection of naked plasmid DNA is a simple yet effective in vivo gene delivery method into hepatocytes. It is increasingly being used as a research tool to elucidate mechanisms of gene expression and the role of genes and their cognate proteins in the pathogenesis of disease in animal models. A greater understanding of its mechanism will aid these efforts and has relevance to macromolecular and nucleic acid delivery in general.

METHODS

In an attempt to explore how naked DNA enters hepatocytes the fate of a variety of molecules and particles was followed over a 24-h time frame using fluorescence microscopy. The uptake of some of these compounds was correlated with marker gene expression from a co-injected plasmid DNA. In addition, the uptake of the injected compounds was correlated with the histologic appearance of hepatocytes.

RESULTS

Out of the large number of nucleic acids, peptides, proteins, inert polymers and small molecules that we tested, most were efficiently delivered into hepatocytes independently of their size and charge. Even T7 phage and highly charged DNA/protein complexes of 60-100 nm in size were able to enter the cytoplasm. In animals co-injected with an enhanced yellow fluorescent protein (EYFP) expression vector and fluorescently labeled immunoglobulin (IgG), hepatocytes flooded with large amounts of IgG appeared permanently damaged and did not express EYFP-Nuc. Hepatocytes expressing EYFP had only slight IgG uptake. In contrast, when an EYFP expression vector was co-injected with a fluorescently labeled 200-bp linear DNA fragment, both were mostly (in 91% of the observed cells) co-localized to the same hepatocytes 24 h later.

CONCLUSIONS

The appearance of permanently damaged cells with increased uptake of some molecules such as endogenous IgG raised the possibility that a molecule could be present in a hepatocyte but its transport would not be indicative of the transport process that can lead to foreign gene expression. The HTV procedure enables the uptake of a variety of molecules (as previous studies also found), but the uptake process for some of these molecules may be associated with a more disruptive process to the hepatocytes that is not compatible with successful gene delivery.

摘要

背景

裸质粒DNA经流体动力学尾静脉(HTV)注射是一种简单而有效的向肝细胞进行体内基因递送的方法。它越来越多地被用作一种研究工具,以阐明基因表达机制以及基因及其同源蛋白在动物模型疾病发病机制中的作用。对其机制有更深入的了解将有助于这些研究工作,并且总体上与大分子和核酸递送相关。

方法

为了探究裸DNA如何进入肝细胞,使用荧光显微镜在24小时的时间范围内追踪了多种分子和颗粒的命运。其中一些化合物的摄取与共注射质粒DNA的标记基因表达相关。此外,注射化合物的摄取与肝细胞的组织学外观相关。

结果

在我们测试的大量核酸、肽、蛋白质、惰性聚合物和小分子中,大多数都能有效地进入肝细胞,而与它们的大小和电荷无关。甚至T7噬菌体和大小为60 - 100纳米的高电荷DNA/蛋白质复合物也能够进入细胞质。在与增强型黄色荧光蛋白(EYFP)表达载体和荧光标记免疫球蛋白(IgG)共注射的动物中,充满大量IgG的肝细胞似乎受到永久性损伤,并且不表达EYFP-Nuc。表达EYFP的肝细胞仅摄取少量IgG。相比之下,当EYFP表达载体与荧光标记的200碱基对线性DNA片段共注射时,24小时后两者大多(在91%观察到的细胞中)共定位于同一肝细胞。

结论

一些分子(如内源性IgG)摄取增加的永久性损伤细胞的出现,增加了一种可能性,即一个分子可能存在于肝细胞中,但其转运并不表明能导致外源基因表达的转运过程。HTV方法能够使多种分子被摄取(如先前研究也发现),但其中一些分子的摄取过程可能与对肝细胞更具破坏性的过程相关,而这与成功的基因递送不兼容。

相似文献

1
Mechanism of plasmid delivery by hydrodynamic tail vein injection. I. Hepatocyte uptake of various molecules.通过尾静脉液压注射进行质粒递送的机制。I. 各种分子的肝细胞摄取。
J Gene Med. 2006 Jul;8(7):852-73. doi: 10.1002/jgm.921.
2
The mechanism of naked DNA uptake and expression.裸露DNA摄取与表达的机制。
Adv Genet. 2005;54:3-20. doi: 10.1016/S0065-2660(05)54001-X.
3
Mechanism of plasmid delivery by hydrodynamic tail vein injection. II. Morphological studies.通过尾静脉液压注射进行质粒递送的机制。II. 形态学研究。
J Gene Med. 2006 Jul;8(7):874-88. doi: 10.1002/jgm.920.
4
Hepatocyte targeting of nucleic acid complexes and liposomes by a T7 phage p17 peptide.通过T7噬菌体p17肽实现核酸复合物和脂质体的肝细胞靶向
Mol Pharm. 2006 Jul-Aug;3(4):386-97. doi: 10.1021/mp050108r.
5
Uptake by mouse liver and intracellular fate of plasmid DNA after a rapid tail vein injection of a small or a large volume.快速尾静脉注射小剂量或大剂量质粒DNA后小鼠肝脏的摄取及质粒DNA的细胞内命运
J Gene Med. 2003 Feb;5(2):142-56. doi: 10.1002/jgm.328.
6
Hydrodynamics-based procedure involves transient hyperpermeability in the hepatic cellular membrane: implication of a nonspecific process in efficient intracellular gene delivery.基于流体动力学的方法涉及肝细胞膜的瞬时高通透性:一种非特异性过程在高效细胞内基因递送中的意义。
J Gene Med. 2004 May;6(5):584-92. doi: 10.1002/jgm.541.
7
Hydrodynamics-based transfection of the liver: entrance into hepatocytes of DNA that causes expression takes place very early after injection.基于流体动力学的肝脏转染:导致表达的DNA在注射后很早就进入肝细胞。
J Gene Med. 2004 Aug;6(8):877-83. doi: 10.1002/jgm.574.
8
Naked plasmid DNA transfer to the porcine liver using rapid injection with large volume.采用大容量快速注射法将裸质粒DNA导入猪肝。
Gene Ther. 2006 Dec;13(24):1696-702. doi: 10.1038/sj.gt.3302833. Epub 2006 Jul 27.
9
High volume hydrodynamic injection of plasmid DNA via the hepatic artery results in a high level of gene expression in rat hepatocellular carcinoma induced by diethylnitrosamine.通过肝动脉进行大容量流体动力学注射质粒DNA,可使二乙基亚硝胺诱导的大鼠肝细胞癌中基因表达水平升高。
J Gene Med. 2006 Aug;8(8):1018-26. doi: 10.1002/jgm.930.
10
Intravenous delivery of naked plasmid DNA for in vivo cytokine expression.通过静脉注射裸质粒DNA实现体内细胞因子表达。
Biochem Biophys Res Commun. 2001 Dec 21;289(5):1088-92. doi: 10.1006/bbrc.2001.6100.

引用本文的文献

1
Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models.改善肝细胞癌免疫治疗:从患者和临床前模型中学习。
Gut Liver. 2025 Apr 3;2(1). doi: 10.1038/s44355-025-00018-y.
2
Gene targeting in adult organs using in vivo cleavable donor plasmids for CRISPR-Cas9 and CRISPR-Cas12a.利用体内可切割供体质粒对 CRISPR-Cas9 和 CRISPR-Cas12a 进行成年器官的基因靶向。
Sci Rep. 2024 Mar 31;14(1):7615. doi: 10.1038/s41598-024-57551-8.
3
Inherently Reduced Expression of ASC Restricts Caspase-1 Processing in Hepatocytes and Promotes Plasmodium Infection.
先天低表达 ASC 可限制肝实质细胞中 caspase-1 的加工,并促进疟原虫感染。
J Immunol. 2024 Feb 15;212(4):596-606. doi: 10.4049/jimmunol.2300440.
4
Optimized thyroid transcription factor-1 core promoter-driven microRNA-7 expression effectively inhibits the growth of human non-small-cell lung cancer cells.优化的甲状腺转录因子-1 核心启动子驱动的 microRNA-7 表达可有效抑制人非小细胞肺癌细胞的生长。
J Zhejiang Univ Sci B. 2022 Nov 15;23(11):915-930. doi: 10.1631/jzus.B2200116.
5
Parameters of biliary hydrodynamic injection during endoscopic retrograde cholangio-pancreatography in pigs for applications in gene delivery.猪内镜逆行胰胆管造影术中用于基因递送的胆汁流体动力注射参数
PLoS One. 2021 Apr 28;16(4):e0249931. doi: 10.1371/journal.pone.0249931. eCollection 2021.
6
Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signaling.靶向 EphA2 通过双重抑制 JAK1/STAT3 和 AKT 信号通路抑制肝癌起始和进展。
Cell Rep. 2021 Feb 23;34(8):108765. doi: 10.1016/j.celrep.2021.108765.
7
Base editing: advances and therapeutic opportunities.碱基编辑:进展与治疗机遇。
Nat Rev Drug Discov. 2020 Dec;19(12):839-859. doi: 10.1038/s41573-020-0084-6. Epub 2020 Oct 19.
8
Intracellular interleukin-32γ mediates antiviral activity of cytokines against hepatitis B virus.细胞内白细胞介素-32γ介导细胞因子对乙型肝炎病毒的抗病毒活性。
Nat Commun. 2018 Aug 16;9(1):3284. doi: 10.1038/s41467-018-05782-5.
9
Factor XI promotes hemostasis in factor IX-deficient mice.因子 XI 促进因子 IX 缺乏小鼠的止血。
J Thromb Haemost. 2018 Oct;16(10):2044-2049. doi: 10.1111/jth.14243. Epub 2018 Aug 16.
10
In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy.用于乙肝免疫治疗的HBsAg/CD3双特异性抗体在肝脏中的原位表达
Mol Ther Methods Clin Dev. 2017 Aug 31;7:32-41. doi: 10.1016/j.omtm.2017.08.006. eCollection 2017 Dec 15.